Johnson & Johnson (NYSE: JNJ) open the trading on N/A, with great promise as it jumped 1.79% to $168.45. During the day, the stock rose to N/A and sunk to N/A before settling in for the price of $165.49 at the close. Taking a more long-term approach, JNJ posted a 52-week range of $148.99-$179.92.
The Healthcare sector firm’s twelve-monthly sales growth has been 3.30% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -0.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -4.20%. This publicly-traded company’s shares outstanding now amounts to $2.63 billion, simultaneously with a float of $2.63 billion. The organization now has a market capitalization sitting at $437.09 billion. At the time of writing, stock’s 50-day Moving Average stood at $162.17, while the 200-day Moving Average is $165.72.
It is quite necessary to find out the efficiency of the corporate organization, which has 134500 number of employees on its payroll. It has generated 613,918 per worker during the last fiscal year. Meanwhile, its income per employee was 109,398. The stock had 5.89 Receivables turnover and 0.50 Total Asset turnover. For the Profitability, stocks gross margin was +66.09, operating margin was +24.79 and Pretax Margin of +19.98.
Johnson & Johnson (JNJ) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – General industry. Johnson & Johnson’s current insider ownership accounts for 0.08%, in contrast to 70.00% institutional ownership. According to the most recent insider trade that took place on Dec 07, this organization’s Controller, CAO sold 5,000 shares at the rate of 163.21, making the entire transaction reach 816,050 in total value, affecting insider ownership by 14,215.
Johnson & Johnson (JNJ) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 6/29/2021 suggests? It has posted $2.48 earnings per share (EPS) beating the forecaster’s viewpoint (set at $2.27) by $0.21. This company achieved a net margin of +17.82 while generating a return on equity of 23.97. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.23 per share during the current fiscal year.
Johnson & Johnson’s EPS decrease for this current 12-month fiscal period is -4.20% and is forecasted to reach 10.39 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 8.19% through the next 5 years, which can be compared against the -0.30% growth it accomplished over the previous five years trading on the market.
Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators
Let’s observe the current performance indicators for Johnson & Johnson (JNJ). It’s Quick Ratio in the last reported quarter now stands at 1.10. The Stock has managed to achieve an average true range (ATR) of 2.69. Alongside those numbers, its PE Ratio stands at $25.18, and its Beta score is 0.72. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.78. Similarly, its price to free cash flow for trailing twelve months is now 37.80.
In the same vein, JNJ’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 6.69, a figure that is expected to reach 2.67 in the next quarter, and analysts are predicting that it will be 10.39 at the market close of one year from today.
Technical Analysis of Johnson & Johnson (JNJ)
[Johnson & Johnson, JNJ] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 94.13% While, its Average True Range was 2.85.
Raw Stochastic average of Johnson & Johnson (JNJ) in the period of the previous 100 days is set at 52.35%, which indicates a major fall in contrast to 94.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 18.13% that was higher than 14.12% volatility it exhibited in the past 100-days period.